STAT+: ARPA-H launches $160 million effort to develop custom gene editing drugs
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations.
Now seven labs will get sizable grants.
An ARPA-H program to jump-start custom gene editing treatments was delayed by a change in administrations.
Now seven labs will get sizable grants.